Treatment of rats with heat killed cells (HKC) of Cryptococcus neoformans var. grubii induces cellular activation in spleen and lymphatic nodes

Comparative Immunology, Microbiology and Infectious Diseases

Volumn 34, Issue 4, 2011, Pages 327-334

  Baronetti, José L ^a   Chiapello, Laura S ^a   Garro, Ana P ^a   Masih, Diana T ^a  

^a UNIVERSIDAD NACIONAL DE CÓRDOBA   (Argentina)

Author keywords

Cryptococcus neoformans; Heat killed cells; Innate immunity; Protection; Rats

Indexed keywords

CD86 ANTIGEN; FREUND ADJUVANT; HEAT KILLED CRYPTOCOCCUS NEOFORMANS CELL; HYDROGEN PEROXIDE; IMMUNOLOGIC AGENT; INTERLEUKIN 10; INTERLEUKIN 12; MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 2; NITRIC OXIDE; PHOSPHATE BUFFERED SALINE; SUPEROXIDE; TRANSFORMING GROWTH FACTOR BETA; TUMOR NECROSIS FACTOR; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIGEN EXPRESSION; ARTICLE; CELL ACTIVATION; CELL ADHESION; CELL SECRETION; CELLULAR IMMUNITY; COMBINATION CHEMOTHERAPY; CONTROLLED STUDY; CRYPTOCOCCOSIS; CRYPTOCOCCUS NEOFORMANS; CYTOKINE RELEASE; FEMALE; LYMPH NODE CELL; LYMPHOCYTE PROLIFERATION; METABOLITE; MONOTHERAPY; NONHUMAN; RAT; SPLEEN CELL; TH1 CELL; TH2 CELL; UPREGULATION;

ANIMALS; ANTIGENS, CD86; ANTIGENS, FUNGAL; CELL ADHESION; CELL PROLIFERATION; CELLS, CULTURED; CRYPTOCOCCOSIS; CRYPTOCOCCUS NEOFORMANS; FEMALE; FREUND'S ADJUVANT; GENES, MHC CLASS II; HOT TEMPERATURE; IMMUNITY, CELLULAR; INTERLEUKIN-12; LYMPH NODES; LYMPHOCYTE ACTIVATION; LYMPHOCYTES; RATS; RATS, WISTAR; SPLEEN; TH1-TH2 BALANCE; TUMOR NECROSIS FACTOR-ALPHA; VACCINATION; VACCINES, INACTIVATED;

ANIMALIA; CRYPTOCOCCUS NEOFORMANS VAR. GRUBII; FILOBASIDIELLA NEOFORMANS; RATTUS;

EID: 79960082888     PISSN: 01479571     EISSN: 18781667     Source Type: Journal    
DOI: 10.1016/j.cimid.2011.04.002     Document Type: Article

References (39)

1. Chuck S.L., Sande M.A. Infections with Cryptococcus neoformans in the acquired immunodeficiency syndrome. N Engl J Med 1989, 321:794-799.
2. Mudumbi S.V. Disseminated cryptococcosis in an HIV-negative pregnancy: a case of cryptococcal septic abortion complicating an immunocompetent pregnancy. Int J Infect Dis 2010, 14:351-353.
3. Guevara-Campos J., González-Guevara L., Urbéz-Cano J., Fermín S. Cryptococcus neoformans meningoencephalitis in immunocompetent schoolchildren. Invest Clin 2009, 50:231-239.
4. Cherniak R., Morris L.C., Anderson B.C., Meyer S.A. Facilitated isolation, purification, and analysis of glucuronoxylomannan of Cryptococcus neoformans. Infect Immun 1991, 59:59-64.
5. Cherniak R., Reiss E., Turner S.H. A galactoxylomannan antigen of Cryptococcus neoformans serotype A. Carbohydr Res 1982, 103:239-250.
6. Buchanan K.L., Murphy J.W. What makes Cryptococcus neoformans a pathogen?. Emerg Infect Dis 1998, 4:71-83.
7. Vecchiarelli A., Pietrella D., Dottorini M., et al. Encapsulation of Cryptococcus neoformans regulates fungicidal activity and the antigen presentation process in human alveolar macrophages. Clin Exp Immunol 1994, 98:217-223.
8. Vecchiarelli A., Retini C., Pietrella D., et al. Downregulation by cryptococcal polysaccharide of tumor necrosis factor alpha and interleukin-1 beta secretion from human monocytes. Infect Immun 1995, 63:2919-2923.
9. Kawakami K. Regulation by innate immune T lymphocytes in the host defense against pulmonary infection with Cryptococcus neoformans. Jpn J Infect Dis 2004, 57:137-145.
10. Murphy J.W. Protective cell-mediated immunity against Cryptococcus neoformans. Res Immunol 1998, 149:373-386.
11. Decken K., Köhler G., Palmer-Lehmann K., et al. Interleukin-12 is essential for a protective Th1 response in mice infected with Cryptococcus neoformans. Infect Immun 1998, 66:4994-5000.
12. Collins H.L., Bancroft G.J. Cytokine enhancement of complement-dependent phagocytosis by macrophages: synergy of tumor necrosis factor-alpha and granulocyte-macrophage colony-stimulating factor for phagocytosis of Cryptococcus neoformans. Eur J Immunol 1992, 22:1447-1454.
13. Kawakami K., Tohyama M., Xie Q., Saito A. IL-12 protects mice against pulmonary and disseminated infection caused by Cryptococcus neoformans. Clin Exp Immunol 1996, 104:208-214.
14. Bauman S.K., Huffnagle G.B., Murphy J.W. Effects of tumor necrosis factor alpha on dendritic cell accumulation in lymph nodes draining the immunization site and the impact on the anticryptococcal cell-mediated immune response. Infect Immun 2003, 71:68-74.
15. Huffnagle G.B., Toews G.B., Burdick M.D., et al. Afferent phase production of TNF-alpha is required for the development of protective T cell immunity to Cryptococcus neoformans. J Immunol 1996, 157:4529-4536.
16. D'Andrea A., Aste-Amezaga M., Valiante N.M., et al. Interleukin 10 (IL-10) inhibits human lymphocyte interferon gamma-production by suppressing natural killer cell stimulatory factor/IL-12 synthesis in accessory cells. J Exp Med 1993, 178:1041-1048.
17. Mariano Andrade R., Monteiro Almeida G., Alexandre DosReis G., Alves Melo Bento C. Glucuronoxylomannan of Cryptococcus neoformans exacerbates in vitro yeast cell growth by interleukin 10-dependent inhibition of CD4+ T lymphocyte responses. Cell Immunol 2003, 222:116-125.
18. Parry S.L., Sebbag M., Feldmann M., Brennan F.M. Contact with T cells modulates monocyte IL-10 production: role of T cell membrane TNF-alpha. J Immunol 1997, 158:3673-3681.
19. Shao X., Rivera J., Niang R., Casadevall A., Goldman D.L. A dual role for TGF-beta1 in the control and persistence of fungal pneumonia. J Immunol 2005, 175:6757-6763.
20. Rossi G.R., Cervi L.A., García M.M., et al. Involvement of nitric oxide in protecting mechanism during experimental cryptococcosis. Clin Immunol 1999, 90:256-265.
21. Baronetti J.L., Chiapello L.S., Aoki M.P., Gea S., Masih D.T. Heat killed cells of Cryptococcus neoformans var. grubii induces protective immunity in rats: immunological and histopathological parameters. Med Mycol 2006, 44:493-504.
22. Baronetti J.L., Chiapello L.S., Garro A.P., Masih D.T. Differential activation of peritoneal cells by subcutaneous treatment of rats with cryptococcal antigens. Clin Vaccine Immunol 2009, 16:1213-1221.
23. Rossi G.R., Cervi L.A., Sastre D.A., Masih D.T. Lack of involvement of nitric oxide in the macrophage-mediated inhibition of spleen cell proliferation during experimental cryptococcosis. Clin Immunol Immunopathol 1998, 86:16-26.
24. Bauman S.K., Nichols K.L., Murphy J.W. Dendritic cells in the induction of protective and nonprotective anticryptococcal cell-mediated immune responses. J Immunol 2000, 165:158-167.
25. Archer S. Measurement of nitric oxide in biological models. FASEB J 1993, 7:349-360.
26. Pick E., Keisari Y. Superoxide anion and hydrogen peroxide production by chemically elicited peritoneal macrophages - induction by multiple nonphagocytic stimuli. Cell Immunol 1981, 59:301-318.
27. Mody C.H., Syme R.M. Effect of polysaccharide capsule and methods of preparation on human lymphocyte proliferation in response to Cryptococcus neoformans. Infect Immun 1993, 61:464-469.
28. Rayhane N., Fitting C., Lortholary O., Dromer F., Cavaillon J.M. Administration of endotoxin associated with lipopolysaccharide tolerance protects mice against fungal infection. Infect Immun 2000, 68:3748-3753.
29. Pietrella D., Corbucci C., Perito S., Bistoni G., Vecchiarelli A. Mannoproteins from Cryptococcus neoformans promote dendritic cell maturation and activation. Infect Immun 2005, 73:820-827.
30. Pietrella D., Cherniak R., Strappini C., et al. A. Role of mannoprotein in induction and regulation of immunity to Cryptococcus neoformans. Infect Immun 2001, 69:2808-28014.
31. Blackstock R. Roles for CD40, B7 and major histocompatibility complex in induction of enhanced immunity by cryptococcal polysaccharide-pulsed antigen-presenting cells. Immunology 2003, 108:158-166.
32. Feldmesser M., Mednick A., Casadevall A. Antibody-mediated protection in murine Cryptococcus neoformans infection is associated with pleotrophic effects on cytokine and leukocyte responses. Infect Immun 2002, 70:1571-1580.
33. Alspaugh J.A., Granger D.L. Inhibition of Cryptococcus neoformans replication by nitrogen oxides supports the role of these molecules as effectors of macrophage-mediated cytostasis. Infect Immun 1991, 59:2291-2296.
34. Lovchik J., Lipscomb M., Lyons C.R. Expression of lung inducible nitric oxide synthase protein does not correlate with nitric oxide production in vivo in a pulmonary immune response against Cryptococcus neoformans. J Immunol 1997, 158:1772-1778.
35. Ghosn E.E., Russo M., Almeida S.R. Nitric oxide-dependent killing of Cryptococcus neoformans by B-1-derived mononuclear phagocyte. J Leukoc Biol 2006, 80:36-44.
36. Rossi G.R., Sastre D.A., Rubinstein H.R., Masih D.T. Biochemical basis for the killing of Cryptococcus neoformans by rat peritoneal cells. J Med Vet Mycol 1994, 32:405-414.
37. Koguchi Y., Kawakami K. Cryptococcal infection and Th1-Th2 cytokine balance. Int Rev Immunol 2002, 21:423-438.
38. Nakajima A., Watanabe N., Yoshino S., et al. Requirement of CD28-CD86 co-stimulation in the interaction between antigen-primed T helper type 2 and B cells. Int Immunol 1997, 9:637-644.
39. Kuchroo V.K., Das M.P., Brown J.A., et al. B7-1 and B7-2 costimulatory molecules activate differentially the Th1/Th2 developmental pathways: application to autoimmune disease therapy. Cell 1995, 80:707-718.